At the news
? BEARISHIMPACT 6/10 CLUSTER filed Apr 30, 2026 at 20:00 ET
Multiple Travere Therapeutics insiders, including the CEO, CFO, and CMO, sold shares in the days following strong Q1 2026 earnings and a $400M convertible note offering. Total open-market sales of $2.74M are tiny relative to the $4.1B market cap, but the clustering of sales by top executives after a dilutive capital raise raises governance concerns. The offering represents ~10% dilution, partially offset by robust revenue growth.
- CEO Eric Dube sold $989K worth of shares on May 6 at $43.95.
- CMO Jula Inrig sold $900K on May 4 and $101K on May 5, total $1.0M.
- Total insider open-market sales in the cluster: ~$2.74M (0.07% of market cap).
- Company filed a $400M convertible senior notes offering (424B5) on May 5, representing ~10% of market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access